GlobeNews Wire

BioNTech and DualityBios Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer

Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of heavily pre-treated…

1 month ago

NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification

Largo, FL, April 10, 2026 (GLOBE NEWSWIRE) -- A commission may be earned if you purchase through links in this…

1 month ago

Gentle Patches Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, and Policy Transparency

Los Angeles, CA, April 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not…

1 month ago

City Furniture and GARVEE Explore Omnichannel Retail Collaboration in North America

April 11, 2026 06:00 ET  | Source: Garvee Innovation Inc. Ontario, California, April 11, 2026 (GLOBE NEWSWIRE) -- A high-level…

1 month ago

Cookiy Introduces a User Research Suite That Enables Any AI to Talk to Real People

SAN FRANCISCO, April 11, 2026 (GLOBE NEWSWIRE) -- Cookiy AI today launched a suite of user research tools (Cookiy Skill,…

1 month ago

Alleron Expert Group Marks Six Years of 100% Client Retention, Announces Expanded Cloud Services Portfolio

BOSTON, MA, April 10, 2026 (GLOBE NEWSWIRE) -- Alleron Expert Group (AEG), a Boston-based cloud consulting and managed services firm,…

1 month ago

IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information

Miami, FL, April 10, 2026 (GLOBE NEWSWIRE) -- Affiliate Disclosure: This article contains affiliate links. If readers purchase through these…

1 month ago

ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility

Cheyenne, WY, April 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute…

1 month ago

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

April 10, 2026 17:02 ET  | Source: Replimune, Inc. WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc.…

1 month ago

Michael Carbonara Signs Moms for Liberty Parent Pledge, Reaffirming Commitment to Parental Rights in Floridas 25th Congressional District

Sunrise, Florida, April 10, 2026 (GLOBE NEWSWIRE) -- Michael Carbonara, Republican candidate for Florida’s 25th Congressional District, today signed the…

1 month ago